Daikaffil Chemicals Posts ₹13.35 Cr Revenue, ₹2.14 Cr Net Loss for FY26

CHEMICALS
Whalesbook Corporate News Logo
AuthorIshaan Verma|Published at:
Daikaffil Chemicals Posts ₹13.35 Cr Revenue, ₹2.14 Cr Net Loss for FY26
Overview

Daikaffil Chemicals India Ltd reported a 78% jump in standalone revenue to ₹13.35 crore for FY26, but its net loss widened to ₹2.14 crore. This marks the company's first consolidated financial reporting following the incorporation of a subsidiary.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Daikaffil Chemicals India Ltd Posts Revenue Growth Amidst Wider Net Loss for FY26

Revenue ₹13.35 crore, Net Loss ₹2.14 crore
Reader Takeaway: Topline growth achieved, but profitability remains a challenge. First-time consolidated reporting is a key development.

What just happened

Daikaffil Chemicals India Limited reported its financial results for the year ended March 31, 2026. Standalone revenue from operations increased significantly to ₹13.3475 crore (₹1,334.75 lakh), up from ₹7.4984 crore (₹749.84 lakh) in the previous financial year. However, the company's standalone net loss also widened to ₹2.1407 crore (₹214.07 lakh) from ₹1.5898 crore (₹158.98 lakh) in FY25.

Why this matters

This filing is significant as it represents Daikaffil Chemicals' first-time preparation and reporting of consolidated financial statements. This move follows the incorporation of its subsidiary, Mikusu Global Industries Limited, on August 22, 2025. While revenue growth is a positive sign, the increasing net loss indicates ongoing profitability challenges that investors will be watching closely.

The backstory

Daikaffil Chemicals India Limited operates in the chemicals sector. The incorporation of a new subsidiary is a strategic step, leading to the adoption of consolidated financial reporting standards. This change provides a more comprehensive view of the company's overall financial health and performance across its group entities.

What changes now

The company will now report both standalone and consolidated financial results. The first consolidated report shows a net loss of ₹2.2141 crore (₹221.41 lakh) for FY26. This shift to consolidated reporting offers greater transparency and a clearer picture of the group's financial standing for stakeholders.

Risks to watch

The primary risk remains the widening net loss despite revenue growth. Investors will need to assess the company's strategy to improve profitability and manage its expenses effectively. The performance of the newly incorporated subsidiary, Mikusu Global Industries Limited, will also be crucial.

Auditor Remarks

The statutory auditors, N V C & Associates LLP, have provided an unmodified audit opinion on both the standalone and consolidated financial results. This indicates that the financial statements are presented fairly, in all material respects, in accordance with the applicable accounting standards, despite it being the first year of consolidated reporting without prior-year comparatives.

Context metrics (time-bound)

For the year ended March 31, 2026:

  • Standalone Revenue: ₹13.35 crore
  • Standalone Net Loss: ₹2.14 crore
  • Consolidated Net Loss: ₹2.21 crore

For the year ended March 31, 2025:

  • Standalone Revenue: ₹7.50 crore
  • Standalone Net Loss: ₹1.59 crore

What to track next

Investors should closely monitor Daikaffil Chemicals' future financial reports, paying attention to revenue trends, loss mitigation strategies, and the performance and contribution of its subsidiary, Mikusu Global Industries Limited.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.